Determinants of survival in myelofibrosis patients undergoing allogeneic hematopoietic cell transplantation - Hernández-Boluda, Juan Carlos; Pereira, Arturo; Kröger, Nicolaus; Beelen, Dietrich; Robin, Marie; Bornhäuser, Martin; Angelucci, Emanuele; Vitek, Antonin; Blau, Igor Wolfgang; Niittyvuopio, Riitta; Finke, Jürgen; Cornelissen, Jan J.; et al. (Leukemia, 2021)
Keywords: 692/308/2171; 692/699/1541/1990/2331; Cancer Research; Care and treatment; Clinical decision making; Complications; Critical Care Medicine; Decision making; Development and progression; Europe; Evaluation; Female; Graft rejection; Graft vs Host Disease - etiology; Graft-versus-host reaction; Grafting; Grafts; Hematology; Hematopoietic Stem Cell Transplantation - adverse effects; Hematopoietic Stem Cell Transplantation - methods; Hematopoietic stem cells; Histocompatibility antigen HLA; Humans; Intensive; Internal Medicine; Kaplan-Meier Estimate; Life Sciences; Male; Medicine; Medicine & Public Health; Mortality; Myelofibrosis; Oncology; Primary Myelofibrosis - diagnosis; Primary Myelofibrosis - epidemiology; Primary Myelofibrosis - mortality; Primary Myelofibrosis - therapy; Prognosis; Proportional Hazards Models; Recurrence; Registries; Retrospective Studies; Risk; Stem cell transplantation; Survival; Transplantation; Transplantation, Homologous; Transplants & implants; Treatment Outcome; Europe; Spain